Submit Your Feeds

Business News • PR NewsWire • Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping

Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping
Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping

MONTE CARLO, Monaco, Feb. 18 /PRNewswire-FirstCall/ -- Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today that preliminary data from its ATHENA (Addressing THE Need for Advanced HPV Diagnostics) trial support the importance of screening for human papillomavirus (HPV) genotype

View More : http://www.prnewswire.com/news-releases/preliminary-data-from-roche-athena-cervical-cancer-trial-support-value-of-human-...
Releted News by prnewswire
Rogers Estate Coffees Launches 3 New 'Fairly Traded' Coffee Products and Offers Free Delivery
Daimler Reports Negative Group EBIT of Minus Euro 1.5 Billion for 2009; Positive EBIT of More Than Euro 2.3 Billion Expected for 2010
Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping
VASCO Transforms the eSecurity Landscape by Launching DIGIPASS as a Service (DaaS)(TM) Authentication Service Offering
Home Sitemap Contact Us
© businessNewsNewsNews.com